Evaluating the Utility of Baseline Cardiac Function Screening in Early-Stage Breast Cancer Treatment. Read more about Evaluating the Utility of Baseline Cardiac Function Screening in Early-Stage Breast Cancer Treatment.
First-line treatment patterns and clinical outcomes in patients with HER2-positive and hormone receptor-positive metastatic breast cancer from registHER. Read more about First-line treatment patterns and clinical outcomes in patients with HER2-positive and hormone receptor-positive metastatic breast cancer from registHER.
Systematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma. Read more about Systematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma.
Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium. Read more about Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.
Castration-resistant prostate cancer: targeted therapies and individualized treatment. Read more about Castration-resistant prostate cancer: targeted therapies and individualized treatment.
Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study. Read more about Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study.
Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved? Read more about Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?
The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Read more about The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective.
Immunotherapeutics in development for prostate cancer. Read more about Immunotherapeutics in development for prostate cancer.
Hepatocellular carcinoma: the role of the North American GI Steering Committee Hepatobiliary Task Force and the advent of effective drug therapy. Read more about Hepatocellular carcinoma: the role of the North American GI Steering Committee Hepatobiliary Task Force and the advent of effective drug therapy.
